|
This document is a sample analysis report from Northwest Bioanalytical for 3M, detailing the quantitative determination of PFOS and related compounds in human serum using LC/MS/MS under study protocol EPI-PEuro.
|
— |
AR226-1721
|
K67aEobBNg1ER1jdQOmxk2EY0 |
23 |
|
This document is a sample analysis report from Northwest Bioanalytical for the quantitative determination of PFOS and related compounds in human serum and plasma, prepared for 3M Company under study protocol EPI-0012.
|
— |
AR226-1720
|
1yNp0QEK7Dq1p9gXoBXzD3kpo |
90 |
|
This document is a sample analysis report prepared by Northwest Bioanalytical for 3M, detailing the quantitative determination of PFOS and related fluorochemicals in human serum using LC/MS/MS under study protocol EPI-Swed.
|
— |
AR226-1722
|
r6m0V4d90B2EEOjNeakOegrkq |
24 |
|
This is a TSCA NCIC Notification Form indicating that the document contains confidential business information protected under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1248
|
jg0ew44EDLpOo778K80zO9O55 |
1 |
|
This is a TSCA NCIC Notification Form for confidential business information (CBI) documents, indicating the document is protected under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1249
|
7M9njKZ9DvndbKobpR0OwK6GV |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1250
|
1yyQjyx72NqbYeJEKZp1MnVZK |
1 |
|
This is a TSCA NCIC Notification Form for confidential business information related to a document claimed under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1251
|
ymkY0m56wBrYE0BKL91qarB63 |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1252
|
Dv1weraEmYJoRRr1ovEObddRd |
1 |
|
Unreadable document.
|
— |
AR226-1253
|
npOEde9RKEbvkE6QbKjo0454z |
1 |
|
This is a TSCA NCIC Notification Form for confidential business information related to a document claimed under Section 14 of the Toxic Substances Control Act, with no analytical content retained in the OCR.
|
— |
AR226-1254
|
25JMpyEzGDy9mKDayYyoXvEg |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1255
|
RpoJOL7EBXn8RzV045KOepaZk |
1 |
|
This is a TSCA NCIC Notification Form with a Document Control Number, but the content is largely unreadable due to OCR errors.
|
— |
AR226-1256
|
VGVkjDVQ2Q9N63v0R1gYzqN64 |
1 |
|
This is a TSCA NCIC Notification Form for confidential business information related to a document claimed under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1257
|
Ybdk8b26O3Lj8Gp1YLnN08g0 |
1 |
|
The document discusses a study on the potential interference of Perfluorooctane Sulfonic Acid Potassium Salt with cholesterol measurements in rats, detailing the method used for cholesterol determination and presenting serum cholesterol concentration results.
|
— |
AR226-1726
|
np0x0dgZkXq9jEv8BmjJbQ5rm |
1 |
|
The document outlines a study conducted by 3M to evaluate the oral toxicity of perfluorooctanesulfonyl fluoride (POSF) in rats, focusing on preliminary data from single-dose exposures at varying levels.
|
— |
AR226-1728
|
M4JOGjK95zOLVb2og990LLw77 |
7 |
|
This is a TSCA NCIC Notification Form for confidential business information documents, with no analytical content retained in the OCR.
|
— |
AR226-1481
|
zQ73z5X563M1GJZOOnoLwK0L7 |
1 |
|
This is a figure from a RCRA Facility Investigation at the 3M Decatur site, illustrating sampling locations for monitor wells sampled on 3/28/01 and 7/16/03.
|
— |
AR226-1484
|
rXw35BeRgv9qrzBYrJKZwxzJ |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under the Toxic Substances Control Act.
|
— |
AR226-1487
|
v1gQRVmoyBO1VpOMq46NjV9Bq |
1 |
|
Unreadable document.
|
— |
AR226-1488
|
mqrmD4897vv2rV4NM8B9YGXa0 |
2 |
|
The document outlines a study by DuPont (Project Number: DuPont-13267) investigating the age effect on plasma concentration of Ammonium Perfluorooctanoate in post-weaning rats following oral gavage.
|
— |
AR226-1491
|
n94eVzLpDyd0L1BxM99Z0dRGm |
8 |
|
This document outlines the protocol for a pharmacokinetic study on perfluorooctanoic acid (PFOA) conducted by DuPont, focusing on inhalation exposure in rats.
|
— |
AR226-1490
|
3J161XmaZoBmBd469z55j6DBD |
13 |
|
This document outlines a pharmacokinetic study conducted by DuPont on perfluorooctanoic acid (PFOA) in rats, focusing on lactational and placental transport.
|
— |
AR226-1492
|
Qk9Qra1GL8Xqk34DJ11Edxxy7 |
13 |
|
The document discusses the environmental and health concerns surrounding perfluorinated compounds (PFCs), particularly PFOA, highlighting their widespread use in consumer products like Scotchgard and the increasing regulatory focus by the EPA due to emerging scientific evidence of their harmful effects.
|
— |
AR226-1506
|
m7Y8eK8L3OZdKarMMyEJnJ7B |
68 |
|
This analytical report by Exygen Research, requested by 3M Environmental Technology and Safety Services, details the total perfluorooctanesulfonate (PFOS) content found in mallard and quail egg yolk samples, including the distribution of PFOS across different fractions of the yolk.
|
— |
AR226-1745
|
XRgxMzyXj2Qo7aD14JMNp1aax |
64 |
|
Unreadable document.
|
— |
AR226-1513
|
Rpm7go136krjaa6ovk4K9KjEz |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under TSCA, with instructions for accessing it through the EPA's CBIC for those with TSCA CBI clearance.
|
— |
AR226-1514
|
3waG474jp5gMJ4xJOY8G4p4y |
1 |
|
This is a TSCA NCIC Notification Form for confidential business information related to a document claimed under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1515
|
B8dZ8E94bm7MD8K31xOJDwYko |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1537
|
6RayGK59G48o35e2yrynXMpv9 |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1543
|
yr5B1J53oG5zY56MnbQypv36V |
1 |
|
This document is a TSCA Section 8(c) allegation form regarding significant adverse reactions, reviewed by V. L. Power, and includes a summary of the allegation related to chemical exposure in the Teflon area, indicating that the chemicals are not known to cause male infertility.
|
— |
AR226-1549
|
Jv8daMqRvjqd9BmrKaO9Kgzoe |
13 |
|
This is an aquatic toxicity data sheet from the Environmental Engineering Laboratory detailing a test on a material with various parameters including organism exposure, dilution water characteristics, and observed mortality rates over multiple time intervals.
|
— |
AR226-1756
|
dY3aX2eo3dyJkONMvx11Ve8Me |
1 |
|
The document presents ecotoxicological testing results for PFOS, detailing various effect concentrations and no-observed effect concentrations (NOEC) across multiple aquatic and avian species, indicating significant inhibition and toxicity at high concentrations.
|
— |
AR226-1757
|
gDQMNzdommpVY34bVZ8Eg7q8N |
1 |
|
This document is an addendum to a 96-hour static acute toxicity test of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) conducted by Wildlife International Ltd. for 3M Corporation, which includes a revision of test results based on updated purity analyses.
|
— |
AR226-1758
|
aDDxGmD81Y4rr7O3d9BQ7NGKR |
7 |
|
The document outlines a blood sampling program for employees at Washington Works to assess levels of C-8 (PFOA) in their blood, focusing on pregnant and non-pregnant females, as well as males, with the aim of providing information for medical counseling and confirming exposure assessments.
|
— |
AR226-1567
|
evM4ByErkx9jDqbVzGNz0EK09 |
4 |
|
The document presents analytical results of PFOA (C-8) levels in samples from Washington Works and other locations, indicating that out of 56 samples from Washington Works, 53 exceeded 0.05 ppm with an average of 0.92 ppm, while samples from other locations showed significantly lower levels.
|
— |
AR226-1572
|
3JjRyaxGXL9rJ1GVnpJ7j45K3 |
2 |
|
This document is an addendum to a 96-hour static acute toxicity test of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) conducted by Wildlife International Ltd. for 3M Corporation, which includes a revision of results based on a purity adjustment from 90.49% to 86.9%.
|
— |
AR226-1759
|
jgNEJKr3rYGmQv3R52krzELmN |
7 |
|
This document is an addendum to a 96-hour toxicity test of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) conducted by Wildlife International Ltd. for 3M Corporation, which includes a revision of results based on updated purity analysis from 90.49% to 86.9%.
|
— |
AR226-1760
|
qd8KxRzO9GRoaB1ydBM1G0rMR |
8 |
|
This document is an addendum to a study conducted by Wildlife International, Ltd. for 3M Corporation, detailing a 48-hour static acute toxicity test of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) on the cladoceran Daphnia magna, with results revised based on a purity analysis adjustment from 90.49% to 86.9%.
|
— |
AR226-1761
|
9J4KLagpXg5QX35oydB183DQ6 |
7 |
|
This document is an addendum to a study conducted by Wildlife International Ltd. for 3M Corporation, detailing a 96-hour static acute toxicity test of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) on the freshwater mussel (Unio complamatus), with results revised based on a purity of 86.9%.
|
— |
AR226-1762
|
RJyR5z8mvqwMb3490L8p7gOva |
7 |
|
This document is an addendum to a study by Wildlife International Ltd. on PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) that details a 96-hour shell deposition test with the Eastern Oyster (Crassostrea virginica), including a revision of results based on a purity adjustment from 90.49% to 86.9%.
|
— |
AR226-1763
|
GmjkNOn429ybmodD8R5LbKJoN |
7 |
|
This document is an addendum to a study conducted by Wildlife International Ltd. for 3M Corporation, detailing an early life-stage toxicity test of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) on fathead minnows, which includes a revision of results based on updated purity analyses.
|
— |
AR226-1765
|
jB27g12YE7EgYyRKYb29qYDq9 |
7 |
|
This document is an addendum to a toxicity test report conducted by Wildlife International Ltd. for 3M Corporation, detailing a flow-through life-cycle toxicity test of PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) on the saltwater mysid (Mysidopsis bahia), which includes a revision of test results based on updated purity analysis from 90.49
|
— |
AR226-1764
|
3e0aaxj3k3jrdk46aNa4kQG5y |
7 |
|
This document is an addendum to a semi-static life-cycle toxicity test report for PFOS (Perfluorooctane Sulfonic Acid Potassium Salt) conducted by Wildlife International, Ltd. for 3M Corporation, which includes a revision of results based on a purity adjustment from 90.49% to 86.9%.
|
— |
AR226-1766
|
DR452o7RN2jXJJ89B6rR4N4d |
7 |
|
This document reports on a non-GLP study conducted by Wildlife International, Ltd. for 3M Corporation, determining the solubility of PFOS in freshwater, freshwater algal medium, and saltwater, with revised results indicating mean solubility concentrations of 326 mg/L and 378 mg/L in freshwater and freshwater algal medium, respectively, based on a purity of 86.
|
— |
AR226-1767
|
ympr9aEyqgm0zmEk29w79dbmV |
6 |
|
This document is an addendum to a study by Wildlife International, Ltd. on the water solubility of PFOS, commissioned by 3M Corporation, which reports a revised mean solubility concentration of PFOS in NANOpure water as 498 mg a.i./L based on a purity of 86.9%.
|
— |
AR226-1768
|
7ZMEbRYBx14V3Ndr3DE3Y0K8 |
6 |
|
The document is an addendum to a study by Wildlife International, Ltd. on PFOS, detailing a revised analysis of an Activated Sludge Respiration Inhibition Test that corrected the test substance purity from 90.49% to 86.9%, affecting the reported results without recalculating original data.
|
— |
AR226-1769
|
NeVgqn7V2Ze0rjjYy1rQw15np |
6 |
|
The document reports on a study comparing cancer prevalence rates among residents exposed to perfluorooctanoic acid (PFOA) near a Dupont manufacturing plant, finding that both the exposed residents and PFOA-exposed workers have higher cancer prevalence compared to the general population.
|
— |
AR226-1771
|
pm0vnbanBpxYXL4b503MdGjrk |
3 |
|
The document presents a study comparing cancer prevalence rates among residents exposed to PFOA from a nearby facility to those of occupationally exposed workers and the general population, finding that the PFOA-exposed population has a higher overall cancer prevalence rate.
|
— |
AR226-1772
|
byeZrBv1xQEvyD88Nn1b9XdQy |
3 |
|
The document reports on a study comparing cancer prevalence rates among residents exposed to perfluorooctanoic acid (PFOA) near a DuPont manufacturing plant, finding higher overall cancer prevalence in this population compared to both an occupationally exposed group and the general population.
|
— |
AR226-1773
|
pBOKGeRLDD3YbjyXkBroYyDVj |
3 |
|
The document is an analytical report from Exygen Research detailing the air sampling program conducted by DuPont Washington Works, specifically analyzing samples for Perfluorooctanoic Acid (PFOA) using liquid chromatography/mass spectrometry (LCMS).
|
— |
AR226-1776
|
JN4mqQvdvowdNVmqOKp7D9boB |
62 |
|
This analytical report details the air sampling program conducted by DuPont at their Washington Works facility, focusing on the detection of Perfluorooctanoic Acid (PFOA) in air samples collected on OVS tubes, analyzed by Exygen Research using liquid chromatography/mass spectrometry.
|
— |
AR226-1776
|
vVv43qQZZ8q2kRoBDjGV0NydZ |
62 |
|
The document is an analytical report from Exygen Research detailing the air sampling results for Perfluorooctanoic Acid (PFOA) collected from DuPont Washington Works, indicating that seven samples were analyzed, with one sample excluded due to collection issues.
|
— |
AR226-1776
|
aJBE6kqrEbqVQogGED8qLNGmB |
63 |
|
This analytical report details the air sampling program conducted by DuPont at their Washington Works facility, focusing on the analysis of Perfluorooctanoic Acid (PFOA) in air samples collected on OVS tubes, with one sample reporting collection issues and no results.
|
— |
AR226-1776
|
10m222kOpKGYbJ6v6RqwwmK5K |
52 |
|
This analytical report details the air sampling program conducted by DuPont at their Washington Works facility, focusing on the analysis of Perfluorooctanoic Acid (PFOA) in air samples collected on OVS tubes, with results for one sample excluded due to collection issues.
|
— |
AR226-1776
|
vyQxZbzNmb3RVVLO026bZ5B19 |
59 |
|
This analytical report from Exygen Research details the air sampling program conducted by DuPont Washington Works, specifically analyzing samples for Perfluorooctanoic Acid (PFOA) using liquid chromatography/mass spectrometry, with results indicating concentrations below detection limits.
|
— |
AR226-1776
|
65yKn9errDg1RLvrZORG3XMj3 |
66 |
|
This analytical report details the air sampling results for Perfluorooctanoic Acid (PFOA) from DuPont's Washington Works, conducted by Exygen Research, noting that results for one sample were not reported due to a sampler malfunction.
|
— |
AR226-1776
|
Znq8VQr12xB4YOp5Gy5nmN9NZ |
64 |
|
This analytical report from Exygen Research details the air sampling program conducted by DuPont Washington Works, specifically analyzing samples for Perfluorooctanoic Acid (PFOA) using liquid chromatography/mass spectrometry (LCMS).
|
— |
AR226-1776
|
ppRZM3ypzK2yzbk577ZMq1Yk7 |
61 |
|
This analytical report from Exygen Research details the air sampling program conducted for DuPont Washington Works, specifically analyzing samples for Perfluorooctanoic Acid (PFOA) using liquid chromatography/mass spectrometry (LCMS).
|
— |
AR226-1776
|
5b49VMKo9O8DEY40wDjmXrEjV |
76 |
|
The document outlines a proposed blood sampling program for employees at Mitsui Fluorochemicals Co. Ltd. in Japan to assess potential exposure to C-8 (perfluorooctanoic acid, PFOA) by comparing dispersing agent values at their facility with those at DuPont's Washington Works, where C-8 has been used for over 25 years.
|
— |
AR226-1600
|
YGJkzz8Rv3xQVX5GVo6nVxp3n |
5 |
|
Unreadable document.
|
— |
AR226-1601
|
rxv5nYMV6np8NXarpOD7XYn0E |
5 |
|
The document reports the analysis of blood samples for perfluorooctanoate (PFOA) conducted by E. I. du Pont de Nemours and Company, detailing the concentrations found in various samples collected in September 1981.
|
— |
AR226-1604
|
pRaaJ8KZ4XyEJGLMXqk3MONw |
5 |
|
The document reports the analysis of 37 blood samples for perfluorooctanoate (PFOA) using gas chromatography, detailing sample identification and concentration results.
|
— |
AR226-1610
|
0EerQ7jLqp67YDwOzBrX7Ymm |
3 |
|
Unreadable document.
|
— |
AR226-1618
|
qmR2DDZMN7MLwbdKGRK8bNqKE |
5 |
|
Unreadable document.
|
— |
AR226-1629
|
821yK0ODvaqpyLRJy1DMy7dLo |
12 |
|
The document presents blood sample results for C-8 (perfluorooctanoic acid, PFOA) levels in workers from Teflon production, showing variations in blood concentrations over time with some samples indicating decreases in PFOA levels.
|
— |
AR226-1630
|
a1E8zxORodwDO35wQ5m5yNM5B |
4 |
|
The document summarizes a meeting regarding the health hazard assessment of C-9, indicating that it does not pose a health risk at low chronic exposure levels, while emphasizing the need for a corporate strategy to eliminate C-9 emissions due to concerns over corporate image and liability.
|
— |
AR226-1632
|
qdNLdmnBdODEMemOG5vo96poj |
12 |
|
The document discusses the detection of PFOA in downstream public water systems, outlines engineering studies for thermal destruction and scrubbing of C-8, and concludes with recommendations for conversion to TBSA and ongoing monitoring of health effects and potential liabilities.
|
— |
AR226-1633
|
v6dNywOLdV1YRYO5L6kx4rOvw |
6 |
|
The document discusses acceptable blood and drinking water levels for ammonium perfluorooctanoate (C-8), recommending a blood concentration of 0.5 ppm for workers and 5 ppb for community drinking water based on exposure and absorption calculations.
|
— |
AR226-1637
|
158BX0XbMn4YYV3bpO5ypaE4j |
2 |
|
The document reports on the fate of FC-143 during the Teflon production process, indicating that 90% of FC-143 is absorbed or incorporated into Teflon, with low levels detected in air samples taken from the operator's breathing zone.
|
— |
AR226-1646
|
XOJ7QpoXGx8YOM3NOQ8Qqmv8w |
3 |
|
The document reports on a study to determine the levels of PFOA (PC-143) in Teflon processing, finding that only 10% of the added PFOA remains as free PFOA in the dispersion, with no detectable levels downstream of the sintering process and no identified exposure risks for operators or customers.
|
— |
AR226-1647
|
oe2j4DDGMLbj8Q5BEoj2Xprq7 |
2 |
|
The document details the analysis of FC-143 (ammonium perfluorooctanoate) levels in Teflon products and production environments, reporting various extraction results and compliance measures related to air sampling and exposure limits.
|
— |
AR226-1651
|
mpjxzmXQ7N1rDneb1d4wMz1YJ |
14 |
|
This analytical report details the air sampling program conducted by DuPont at their Washington Works facility, focusing on the analysis of Perfluorooctanoic Acid (PFOA) in air samples collected on OVS tubes, with specific methods and sample handling outlined.
|
— |
AR226-1776
|
vy9w6vNmYo1r655rB6kw88zp6 |
52 |
|
This analytical report from Exygen Research presents the characterization of filter samples received from DuPont Corporation, specifically analyzing 29 samples for perfluorooctanoic acid (PFOA) using liquid chromatography/tandem mass spectrometry (LC/MS/MS).
|
— |
AR226-1777
|
5k6a11VXo1v6NNJQxwVN5eo8R |
164 |
|
The document discusses interim processes for eliminating or controlling FC-143 exposure at Spruance, detailing toxicological studies, thermal treatment methods for removing FC-143 from packing yarns, and initial promising results with a new surfactant, while highlighting challenges with yarn stiffness due to over-drying.
|
— |
AR226-1654
|
mqXGwG8D8b17nv54QJM40O5oO |
27 |
|
The document reports on the concentration of ammonium perfluoro octanoate (C8) in wastewater from Teflon production at E. I. Du Pont de Nemours & Co., indicating that while the company has set a Community Exposure Guideline of 1 ppb, the estimated average concentration in the James River would be 0.10 ppb, with potential exceedance only during
|
— |
AR226-1661
|
OEmVmE5ree92geEpeNgvYYE21 |
14 |
|
The document discusses concerns regarding the concentration of C-8 (perfluorooctanoic acid, PFOA) in shaving products, correcting an error in reported levels and recommending against its use due to potential health risks associated with skin contact.
|
— |
AR226-1664
|
GKnp4oLRbXJgpDrRDKKgda9YY |
2 |
|
The document summarizes groundwater sampling results from March 2003, indicating that C8 (likely PFOA) concentrations in the first aquifer have increased to 14.4 µg/L, with various samples collected from monitoring wells and treatment systems at the site.
|
— |
AR226-1670
|
YrqobvoR4rX87rn97VDqvYYyO |
13 |